• Portfolio
  • People
  • News
  • Investors

Make more possible

  • People
  • Portfolio
  • Insights
  • Investors
  • News
  • Press
  • Opportunities
  • Our Ethic
  • Contact Us
Submit a proposal

Stay connected

Latest insight

Our Strategy in Action: Realisations

Our Strategy in Action: Realisations

Chief Portfolio Officer takes us through the realisations story for FY25

Richard Marsh
Richard Marsh

Medtech News

See all Molten News

Healthcare

Molten participates in $42 million Series B in Aktiia as it rebrands to Hilo

Molten is pleased to announce it has participated in an oversubscribed $40 million Series B funding round for Aktiia, a blood pressure intelligence platform, as the company announces its new brand identity Hilo

Healthcare

Molten invests in PocDoc, a digital diagnostics startup

Molten has invested in the £10 million seed round of PocDoc, a Cambridge-based digital diagnostics company.

Healthcare

Molten Ventures leads $12 Million Series A in Anima

Molten Ventures has led an oversubscribed Series A funding round of $12 million in Anima, the next generation care enablement platform. Anima’s operating system for clinics resolves 85% of patient inquiries within 24 hours.

Healthcare

IMU Biosciences raises £11.5 million Series A

IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine.

Healthcare

Draper Esprit leads $17.5m Series A in health-tech, Aktiia

Draper Esprit is thrilled to lead US$ 17.5m Series A investment in hypertension health-tech firm Aktiia.

Page 1 of 1

Keep up to date with the latest news, investments & Financial updates. Please see our Privacy Policy to see how we handle your data.

Thank you!

You’ll now be updated with the latest Molten news.

About
  • Our People
  • Our Ethic
  • Our Rebrand
Portfolio
  • Companies
  • Seed Funds
  • Submit a Proposal
Updates
  • Insights
  • News
  • Opportunities
Information
  • Contact Us
  • Press
  • Investor Relations

Stay connected

Make More Possible

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Modern Slavery Statement
  • Site Map
  • Investor Relations
  • Contact Us

Copyright 2025

We use cookies to enhance your online browsing experience. By continuing to use this site, you agree to accept our use of cookies. Read our Cookie Policy to find out more.